Most interestingly, the authors also demonstrated that inhibition of L-Kyn production by pharmacological blockade of TDO could decrease the activation of AHR signaling and reduce infarct volume in the MCAO stroke model. This evidence concerns the gene TDO2 and stroke disorder.